Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SPHERE Per-AF Post-Approval Study, an Addendum to the Affera Global Registry

NCT06858306 is registered in ClinicalTrials.gov with Medtronic Cardiac Ablation Solutions as lead sponsor.

NCT NCT06858306
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06858306 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SPHERE Per-AF Post-Approval Study, an Addendum to the Affera Global Registry
Lead sponsor
Medtronic Cardiac Ablation Solutions
Phase
Observational
Overall status
Active, not recruiting
Start date
September 25, 2025
Completion date
October 31, 2030
Enrollment
200 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

persistent atrial fibrillation